BedMed-Frail: Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations?
NCT04054648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 776
Last updated 2024-08-27
Summary
High blood pressure (present in 1 of 5 Canadian adults) increases the risk of heart attack and stroke. Blood pressure lowering pills reduce this risk - but perhaps not optimally. A Spanish study suggests that using blood pressure pills at bedtime, instead of in the morning (when they are most commonly used), reduces death, heart attack, and stroke by more than 50%. If true, a switch to bedtime prescribing would have more impact on the health of those with high blood pressure than whether high blood pressure is treated at all.
BedMed, a community-based Canadian primary care trial, is already running and looking both to validate the findings of this Spanish study and to determine whether there might be unrecognized harms of bedtime use (such as more falls and fractures as a result of lower overnight blood pressure). One very important population that is likely to be more sensitive to the effects of medications, and almost always excluded from randomized trials, are the frail elderly (such as those who are resident in nursing homes). In order to have the greatest information about the safety and effectiveness of bedtime blood pressure medications, the BedMed team is additionally conducting a similar trial to BedMed in nursing homes ("BedMed-Frail" - the subject of this trial registration) to determine whether the risks and benefits of bedtime prescribing differ in this highly understudied population.
Basics of the trial: When patients are admitted to nursing homes, neither they nor their physicians are consulted about the timing of blood pressure medication. Unless explicitly stated to be otherwise, blood pressure pills are instead largely arbitrarily assigned for morning use by default. Given there is evidence that bedtime administration may be safer, the nursing homes participating in BedMed-Frail will have each hypertensive resident randomized to either continue with morning blood pressure medication use, as is their norm, or to have their facility's pharmacist gradually switch each residents blood pressure pills to bedtime. Over a period of roughly 3 years, health outcomes in these facilities will be tracked using routinely collected electronic health data to determine differences in things like hospitalization, death, or hip fractures - and at the end of the study the investigators hope to determine whether or not the recommendations for blood pressure medication timing in frail older adults should differ from those for the general population.
Conditions
Interventions
- OTHER
-
Bedtime administration of the participant's pre-existing antihypertensive medications
Changing the administration time of once daily blood pressure lowering medications, one at a time as tolerated, from morning to bedtime.
Sponsors & Collaborators
-
Alberta Innovates Health Solutions
collaborator OTHER -
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV -
EnACt
collaborator UNKNOWN -
Alberta Health services
collaborator OTHER -
University of Alberta
lead OTHER
Principal Investigators
-
Scott R Garrison, MD, PhD · University of Alberta
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-25
- Primary Completion
- 2024-02-29
- Completion
- 2024-02-29
Countries
- Canada
Study Locations
More Related Trials
-
Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension
NCT00994617 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Chlorthalidone and Hydrochlorothiazide Combined With Amiloride on Blood Pressure in Primary Hypertension.
NCT03928145 ·Status: UNKNOWN ·Phase: PHASE3
-
Diurnal Variation in Hypertensive Stroke Patients
NCT01830517 ·Status: COMPLETED ·Phase: PHASE4
-
Filtered Trial for Amlodipine Non-responder
NCT00558064 ·Status: COMPLETED ·Phase: PHASE3
-
Fimasartan/Amlodipine Combination Phase III
NCT02152306 ·Status: COMPLETED ·Phase: PHASE3
-
Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension
NCT00170950 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure
NCT06692764 ·Status: COMPLETED ·Phase: PHASE2
-
Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension
NCT02177461 ·Status: COMPLETED ·Phase: PHASE4
-
INVEST: INternational VErapamil SR Trandolapril STudy
NCT00133692 ·Status: COMPLETED ·Phase: PHASE4
-
Ramipril - Hypertension
NCT00325806 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
NCT00946829 ·Status: COMPLETED
-
Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
NCT00558428 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension
NCT00473174 ·Status: COMPLETED ·Phase: PHASE4
-
High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients
NCT00313547 ·Status: TERMINATED ·Phase: PHASE4
-
Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril
NCT00394394 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)
NCT01370655 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
NCT00232882 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
NCT00316095 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effects of Ramipril Combined With Candesartan
NCT00356395 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
NCT00509470 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)
NCT00754429 ·Status: COMPLETED ·Phase: PHASE4
-
Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT
NCT00147563 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)
NCT00240474 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
NCT02294539 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
NCT05331144 ·Status: RECRUITING ·Phase: PHASE2